Studies reveal context‐dependent effects of IL‐17A in cancer, demonstrating instances of Th17‐mediated anti‐tumor immunity and IL‐17A‐producing cells contributing to CD8+ T cell exhaustion in melanoma, ultimately enhancing the efficacy of immunotherapeutic approaches. Here, IL17A is linked to melanoma.